Steven A. Fuller

1.1k total citations
37 papers, 778 citations indexed

About

Steven A. Fuller is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Epidemiology. According to data from OpenAlex, Steven A. Fuller has authored 37 papers receiving a total of 778 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 14 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Epidemiology. Recurrent topics in Steven A. Fuller's work include Monoclonal and Polyclonal Antibodies Research (13 papers), Glycosylation and Glycoproteins Research (7 papers) and Biochemical and Molecular Research (6 papers). Steven A. Fuller is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (13 papers), Glycosylation and Glycoproteins Research (7 papers) and Biochemical and Molecular Research (6 papers). Steven A. Fuller collaborates with scholars based in United States, Canada and Australia. Steven A. Fuller's co-authors include Scott Winston, Sean R. Gallagher, John G.R. Hurrell, Miyoko Takahashi, Ali Fattom, Peter Hornbeck, Chiayung Chu, Robert Naso, Louis Fries and Jusuf Zlatanic and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Blood.

In The Last Decade

Steven A. Fuller

37 papers receiving 754 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steven A. Fuller United States 15 446 154 106 97 84 37 778
Carolina E. Caffaro United States 11 449 1.0× 119 0.8× 47 0.4× 81 0.8× 106 1.3× 20 724
Hervé Ginisty France 10 914 2.0× 106 0.7× 85 0.8× 54 0.6× 94 1.1× 11 1.3k
Lynne J. Lawrence Australia 15 479 1.1× 275 1.8× 195 1.8× 67 0.7× 77 0.9× 18 866
Javier Delgado Spain 18 900 2.0× 128 0.8× 72 0.7× 178 1.8× 80 1.0× 33 1.3k
Ross Chambers United States 13 689 1.5× 137 0.9× 101 1.0× 178 1.8× 91 1.1× 21 919
Glenn Dawes United States 11 658 1.5× 40 0.3× 97 0.9× 143 1.5× 78 0.9× 12 915
Nicholas Flint Switzerland 11 617 1.4× 176 1.1× 82 0.8× 188 1.9× 259 3.1× 20 1.0k
H. Okayama Japan 11 533 1.2× 81 0.5× 59 0.6× 138 1.4× 138 1.6× 24 1.0k
Ricardo Kratje Argentina 18 684 1.5× 63 0.4× 215 2.0× 200 2.1× 128 1.5× 63 991
F. Roubinet France 22 398 0.9× 124 0.8× 75 0.7× 280 2.9× 266 3.2× 65 1.4k

Countries citing papers authored by Steven A. Fuller

Since Specialization
Citations

This map shows the geographic impact of Steven A. Fuller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven A. Fuller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven A. Fuller more than expected).

Fields of papers citing papers by Steven A. Fuller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven A. Fuller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven A. Fuller. The network helps show where Steven A. Fuller may publish in the future.

Co-authorship network of co-authors of Steven A. Fuller

This figure shows the co-authorship network connecting the top 25 collaborators of Steven A. Fuller. A scholar is included among the top collaborators of Steven A. Fuller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven A. Fuller. Steven A. Fuller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Zhi-Gang, et al.. (2018). PAN-811 prevents chemotherapy-induced cognitive impairment and preserves neurogenesis in the hippocampus of adult rats. PLoS ONE. 13(1). e0191866–e0191866. 17 indexed citations
2.
Revskaya, Ekaterina, Zewei Jiang, Alfred Morgenstern, et al.. (2017). A Radiolabeled Fully Human Antibody to Human Aspartyl (Asparaginyl) β -Hydroxylase Is a Promising Agent for Imaging and Therapy of Metastatic Breast Cancer. Cancer Biotherapy and Radiopharmaceuticals. 32(2). 57–65. 10 indexed citations
3.
Jiang, Zhi-Gang, Steven A. Fuller, & Hossein Ghanbari. (2015). PAN‐811 Blocks Chemotherapy Drug‐Induced In Vitro Neurotoxicity, While Not Affecting Suppression of Cancer Cell Growth. Oxidative Medicine and Cellular Longevity. 2016(1). 9392404–9392404. 7 indexed citations
4.
Fuller, Steven A., et al.. (2013). Immunogenicity of a lambda phage-based anti-cancer vaccine targeting HAAH. Journal for ImmunoTherapy of Cancer. 1(Suppl 1). P210–P210. 1 indexed citations
5.
Fahim, Raafat, Paul Kessler, Steven A. Fuller, & Matthew W. Kalnik. (2011). Nicotine Vaccines. CNS & Neurological Disorders - Drug Targets. 10(8). 905–915. 15 indexed citations
6.
Gallagher, Sean R., et al.. (2008). Immunoblotting and Immunodetection. Current Protocols in Immunology. 83(1). 8.10.1–8.10.28. 84 indexed citations
7.
Lee, David D., Shivakumar Chitturi, James G. Kench, et al.. (2003). Transjugular liver biopsy effecting changes in clinical management. Australasian Radiology. 47(2). 117–120. 8 indexed citations
8.
9.
Korelitz, Burton I., et al.. (1999). Allergic Reactions to 6-Mercaptopurine During Treatment of Inflammatory Bowel Disease. Journal of Clinical Gastroenterology. 28(4). 341–344. 35 indexed citations
10.
11.
Fuller, Steven A., Miyoko Takahashi, & John G.R. Hurrell. (1997). Purification of Monoclonal Antibodies. Current Protocols in Molecular Biology. 37(1). Unit11.11–Unit11.11. 5 indexed citations
12.
Fuller, Steven A., Miyoko Takahashi, & John G.R. Hurrell. (1992). Preparation of Myeloma Cells. Current Protocols in Molecular Biology. 18(1). Unit11.5–Unit11.5. 3 indexed citations
13.
Hornbeck, Peter, Scott Winston, & Steven A. Fuller. (1991). Enzyme‐Linked Immunosorbent Assays (ELISA). Current Protocols in Molecular Biology. 15(1). Unit11.2–Unit11.2. 39 indexed citations
14.
Fuller, Steven A., et al.. (1989). Enhancement of hybridoma production by medium supplemented with murine ascitic fluid. Journal of Immunological Methods. 123(1). 45–53. 7 indexed citations
15.
Fuller, Steven A., Miyoko Takahashi, & John G.R. Hurrell. (1988). Cloning of Hybridoma Cell Lines by Limiting Dilution. Current Protocols in Molecular Biology. 1(1). Unit11.8–Unit11.8. 32 indexed citations
16.
Takahashi, Miyoko, Steven A. Fuller, & John G.R. Hurrell. (1987). Production of IgG-producing hybridomas by in vitro stimulation of murine spleen cells. Journal of Immunological Methods. 96(2). 247–253. 15 indexed citations
17.
Nagainis, Peter A., et al.. (1986). A rapid quantitative capillary tube enzyme immunoassay for human chorionic gonadotropin in urine. Clinica Chimica Acta. 160(3). 273–279. 7 indexed citations
18.
Fuller, Steven A., John J. Hutton, John R. Meier, & Mary Sue Colemán. (1982). Deoxynucleotide-interconverting enzymes and the quantification of deoxynucleoside triphosphates in mammalian cells. Biochemical Journal. 206(1). 131–138. 17 indexed citations
19.
Hutton, John J., et al.. (1981). Biochemical and Functional Abnormalities in Lymphocytes from an Adenosine Deaminase-deficient Patient during Enzyme Replacement Therapy. Journal of Clinical Investigation. 68(2). 413–421. 29 indexed citations
20.
Fuller, Steven A. & Allan J. Morris. (1981). Thermolability characteristics and inheritance of human red cell nucleoside triphosphate pyrophosphohydrolase. Biochemical Genetics. 19(9-10). 955–970. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carolina E. Caffaro Breakdown of academic impact, for papers by Hervé Ginisty Breakdown of academic impact, for papers by Lynne J. Lawrence Breakdown of academic impact, for papers by Javier Delgado Breakdown of academic impact, for papers by Ross Chambers Breakdown of academic impact, for papers by Glenn Dawes Breakdown of academic impact, for papers by Nicholas Flint Breakdown of academic impact, for papers by H. Okayama Breakdown of academic impact, for papers by Ricardo Kratje Breakdown of academic impact, for papers by F. Roubinet
Rankless by CCL
2026